<DOC>
	<DOCNO>NCT01753440</DOCNO>
	<brief_summary>The aim present study investigate safety efficacy intramyocardial implantation allogeneic mesenchymal stem cell patient ischemic cardiomyopathy time coronary artery bypass grafting .</brief_summary>
	<brief_title>Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting Patients With Ischemic Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Age 18 75 year Severe coronary artery disease amenable surgical revascularization accord current guideline History acute myocardial infarction least 14 day previously Left ventricular ejection fraction ( LVEF ) â‰¤ 40 % assessed echocardiography Distinct area dyskinetic akinetic leave ventricular myocardium correspond infarct localization Patient 's informed consent obtain Emergency operation Debilitating chronic disease ( eg . malignancy terminal renal failure ) Concomitant valve surgery Previous cardiac surgery Malignant ventricular arrhythmia Haematologic disease Woman reproductive age Severe psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>heart failure</keyword>
	<keyword>stem cell implantation</keyword>
</DOC>